The Department of Health (DOH) said yesterday it is launching a pilot project to recruit overseas-based Taiwanese doctors to work in remote areas of the country in five major specialties.
2012/11/8 |
 | GlaxoSmithKline (GSK), a world-leading research-based pharmaceutical company, and the Children's Epilepsy Association of Taiwan (台灣兒童伊比力斯協會) yesterday co-hosted a Halloween party at Tamsui Fisherman's Wharf (淡水漁人碼頭), giving children with epilepsy a chance to participate in a costume party, trick-or-treating and turning pumpkins into jack-o'-lanterns.
2012/10/15 |
Taiwan and Canada officially began a project Thursday aimed at developing preventive vaccines against hospital acquired infections, Science Minister Cyrus Chu announced Thursday during a visit to Toronto.
2012/9/8 |
Adults who inhaled steroids as children to control their asthma may be shorter than they otherwise would have been, but only by a little, U.S. researchers said on Monday.
2012/9/4 |
A National Tsing Hua University research team has made a breakthrough in bio-imaging technology that will enable researchers to study stem cells more closely and cheaply.
2012/8/30 |
The U.S. Food and Drug Administration (FDA) warned physicians and caregivers on Wednesday about the risks of giving the pain reliever codeine to children who have just had surgery to treat obstructive sleep apnea.
2012/8/17 |
 | The top 10 imported Chinese medicines are to require safety certification beginning Aug. 1, as well as improved labeling, a Department of Health (DOH) official said yesterday.
2012/7/25 |
 | U.S. regulators on Tuesday approved the second new anti-obesity drug in 13 years, Qsymia, for use with exercise and a good diet in people who are obese or overweight with certain medical problems.
2012/7/19 |
The first-ever daily pill to help prevent against HIV was approved Monday by U.S. regulators for use in uninfected adults who are at risk for getting the virus that causes AIDS.
2012/7/18 |
ScinoPharm Taiwan Ltd., one of the leading biotechnology companies in the country, said Friday it plans to invest NT$1.1 billion (US$37.6 million) in a project to manufacture high-potency injectable drugs for cancer treatment.
2012/7/1 |
